Norman Fields Gottscho Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Norman Fields Gottscho Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-101,636	Closed	-$6.33M	–	73
2015 Q1	$6.33M	Sell	101,636 -2,966	-3%	-$172K	4%	7
2014 Q4	$6.02M	Sell	104,602 -959	-0.9%	-$53.4K	3.94%	9
2014 Q3	$5.67M	Sell	105,561 -1,000	-0.9%	-$53K	3.77%	7
2014 Q2	$5.59M	Sell	106,561 -218	-0.2%	-$11.1K	3.56%	7
2014 Q1	$5.64M	Buy	106,779 +100	+0.1%	+$4.62K	3.87%	6
2013 Q4	$4.28M	Buy	106,679 +25,424	+31%	+$1M	2.88%	12
2013 Q3	$3.07M	Buy	+81,255	New	+$3.17M	2.3%	17

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Norman Fields Gottscho Capital Management's TEVA Position: Q2 2015 in Review

Norman Fields Gottscho Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 101,636 shares — an estimated $6.33M sold.

Norman Fields Gottscho Capital Management first reported a position in TEVA in Q3 2013 and held it in 7 quarters. The position peaked at $6.33M in Q1 2015. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Norman Fields Gottscho Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Norman Fields Gottscho Capital Management sold 101,636 Teva Pharmaceuticals shares in Q2 2015, an estimated $6.33M.
Norman Fields Gottscho Capital Management first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 7 quarters.
Norman Fields Gottscho Capital Management's Teva Pharmaceuticals position peaked at $6.33M in Q1 2015.
818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q2 2015, filed 14 Jul 2015.